# Isolated dysphagia masking myasthenia gravis diagnosis

**Authors:** Isabella Lopes Lusvarghi, Eduarda Heringer Bernis, Rafaela Gatti Lopes, Rafaela Costa Vieira, Breno Franco Silveira Fernandes, Davi Teixeira Urzêdo Queiroz

PMC · DOI: 10.1055/s-0046-1817045 · 2026-03-11

## TL;DR

A woman with long-term swallowing issues was later diagnosed with myasthenia gravis, a rare autoimmune disease, after a series of tests and treatments.

## Contribution

This case highlights that myasthenia gravis should be considered in patients with persistent unexplained dysphagia.

## Key findings

- Isolated dysphagia can be the initial symptom of myasthenia gravis.
- Corticosteroid therapy may worsen symptoms, prompting neurological evaluation.
- Thymoma was identified as a contributing factor, confirmed through robotic thymectomy.

## Abstract

Myasthenia gravis (MG) is an autoimmune disorder of the neuromuscular junction characterized by fluctuating skeletal muscle weakness. We report a 61-year-old woman presenting with progressive dysphagia as the sole initial symptom for 15 months, leading to diagnostic delay. Esophageal manometry suggested ineffective motility, and electroneuromyography was normal, reinforcing a non-neurological hypothesis. During hospitalization for worsening dysphagia, cervical magnetic resonance imaging (MRI) incidentally revealed an anterior mediastinal nodule consistent with thymoma. Pulse corticosteroid therapy caused abrupt clinical deterioration, prompting neurological evaluation. Pyridostigmine produced marked improvement within 48 hours, and acetylcholine receptor antibody testing confirmed MG (18.7 nmol/L, radioimmunoassay). Robotic thymectomy revealed a type AB thymoma. The patient remains stable on azathioprine 2.5 mg/kg/day, with oncologic follow-up. This case highlights that MG should be considered in persistent unexplained dysphagia, particularly when symptoms worsen after corticosteroid exposure. Early recognition avoids morbidity and unnecessary invasive procedures.

## Linked entities

- **Chemicals:** acetylcholine (PubChem CID 187), pyridostigmine (PubChem CID 4991), azathioprine (PubChem CID 2265)
- **Diseases:** myasthenia gravis (MONDO:0009688), thymoma (MONDO:0006456)

## Full-text entities

- **Diseases:** muscle weakness (MESH:D018908), AB (MESH:D049290), autoimmune disorder of the neuromuscular junction (MESH:D020511), dysphagia (MESH:D003680), MG (MESH:D009157), thymoma (MESH:D013945)
- **Chemicals:** azathioprine (MESH:D001379), Pyridostigmine (MESH:D011729)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12978864/full.md

---
Source: https://tomesphere.com/paper/PMC12978864